SILVERGATE PHARMACEUTICALS INC has a total of 44 patent applications. It decreased the IP activity by 76.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and consumer goods are DELANDALE LAB LTD, GYNOPHARM S A and OHR PHARMA LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 25 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | Canada | 4 | |
#5 | Brazil | 2 | |
#6 | China | 1 | |
#7 | Hong Kong | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Consumer goods |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Footwear features |
# | Name | Total Patents |
---|---|---|
#1 | Mosher Gerold L | 36 |
#2 | Miles David W | 24 |
#3 | Brauer Scott | 12 |
#4 | Rajewski Lian G | 6 |
#5 | Colabuono Peter | 6 |
#6 | Beckloff Michael C | 6 |
#7 | Rajewski Roger A | 6 |
#8 | Segrave Frank | 6 |
#9 | Heppert Kathleen | 6 |
#10 | Mauro Robert | 6 |
Publication | Filing date | Title |
---|---|---|
US2019314279A1 | Amlodipine formulations | |
WO2018067959A1 | Amlodipine formulations | |
US9669008B1 | Enalapril formulations | |
US9463183B1 | Lisinopril formulations |